Volume : 12, Issue : 06, June – 2025
Title:
CELL CYCLE AND MITOSIS: REVIEW OF MECHANISMS, CHECKPOINTS, AND THERAPEUTIC FRONTIERS
Authors :
Dr. Nisha Shri Chengamaraju*, Dr. NVL Suvarchala Reddy, Dr. Ganga Raju,
Dr. M. Lakshmi Madhuri, Ms. Pinnamaneni Sri Sai Nikita Devi, Mr. Maktha Baswaraj, Ms. U. Sai Smriti
Abstract :
Abstract:
Mitosis is a critical process in eukaryotic cell division that ensures genetic material is evenly distributed into two identical daughter cells. This process supports growth, tissue repair, and asexual reproduction in organisms. Mitosis occurs in five main stages: prophase, prometaphase, metaphase, anaphase, and telophase, ending with cytokinesis. It is regulated by cyclins, cyclin-dependent kinases, and checkpoint proteins to maintain genetic stability. Errors in mitotic regulation can cause chromosomal instability, which is often linked to cancer. This report examines the molecular mechanisms of mitosis, its regulation, common errors, and experimental methods used for its study. It also highlights therapeutic developments targeting mitotic pathways, underscoring the significance of mitosis in biology and medicine.
Keywords: Mitotic errors, Cell cycle restriction points, Aurora Kinase Inhibitors, Polo-like Kinase (PLK) Inhibitors, Histone Deacetylase Inhibitors (HDACi)
Cite This Article:
Please cite this article in press Nisha Shri Chengamaraju et al, Cell Cycle And Mitosis: Review Of Mechanisms, Checkpoints, And Therapeutic Frontiers.., Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1. Lalan M, Bagchi T, Misra A. The Cell. In: Misra A, editor. Challenges in Delivery of Therapeutic Genomics and Proteomics. 1st ed. Academic Press; 2011. p. 1-43.
2. Wayne R. The Nucleus. In: Wayne R, editor. Plant Cell Biology. 2nd ed. Academic Press; 2019. p. 373-408.
3. Shi W, Dowdy SF. Cell cycle controls in G1 and G0. Oncogene. 2003;22(42):1065-76.
4. Taylor JH. Physiology of mitosis and meiosis. Annu Rev Plant Physiol. 1961;12:327-44.
5. National Human Genome Research Institute (NHGRI). Mitosis [Internet]. Bethesda (MD): National Human Genome Research Institute; 2025 Apr 20.
6. Brest State A.S. Pushkin University. Inostrannye yazyki i sovremennyi mir: sbornik materialov mezhdunarodnoi nauchnoi konferentsii studentov, magistrantov, aspirantov, Brest, 19 aprelya 2024 g. [Foreign languages and the modern world: proceedings of the international scientific conference of students, master’s and postgraduate students, Brest, April 19, 2024]. Brest: Brest State A.S. Pushkin University; 2024. p. 183.
7. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. 5th ed. New York: Garland Science; 2002.
8. Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, et al. Molecular Cell Biology. 7th ed. New York: W.H. Freeman and Company; 2013.
9. Musacchio A, Desai A. A molecular view of kinetochore assembly and function. Biology. 2017;6(1):5.
10. Lara-Gonzalez P, Pines J, Desai A. Spindle assembly checkpoint activation and silencing at kinetochores. In: Seminars in Cell & Developmental Biology. 2021;117:86-98.
11. Cooper GM, Hausman RO. The Cell: A Molecular Approach. 2nd ed. Sunderland, MA: Sinauer Associates; 2000.
12. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001;2(1):21-32.
13. Morgan DO. The Cell Cycle: Principles of Control. New York: New Science Press; 2007.
14. Mitchison TJ. The kinetochore-microtubule interface: an engineered machine. Cell. 2012;149(5):965-7.
15. Karsenti E, Vernos I. The mitotic spindle: a self-made machine. Science. 2001;294(Suppl 5542):543-7.
16. Jürgens G. Cytokinesis in higher plants. Annu. Rev. Plant Biol.. 2005 Jun 2;56(1):281-99.
17. Glotzer M. The molecular requirements for cytokinesis. Science. 2005 Mar 18;307(5716):1735-9.
18. Wolpert L, Tickle C, Arias AM. Principles of Development. 5th ed. Oxford: Oxford University Press; 2015.
19. Potapova TA, Gorbsky GJ. The consequences of chromosome segregation errors in mitosis and meiosis. Biology (Basel). 2017;6(1):12.
20. Mayo Clinic. Down syndrome – Symptoms and causes [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research;
21. Hosea R, Hillary S, Naqvi S, Wu S, Kasim V. The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduct Target Ther. 2024 Mar 29;9(1):75
22. Johnson A, Skotheim JM. Start and the restriction point. Current opinion in cell biology. 2013 Dec 1;25(6):717-23.
23. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nature reviews cancer. 2009 Mar;9(3):153-66.
24. Pardee AB. A restriction point for control of normal animal cell proliferation. Proceedings of the National Academy of Sciences. 1974 Apr;71(4):1286-90.
25. Latif C, Harvey SH, O’Connell MJ. Ensuring the stability of the genome: DNA damage checkpoints. In: Trescowthick Research Laboratories, Peter MacCallum Cancer Institute. Melbourne: Department of Genetics, University of Melbourne; 2006.
26. Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol. 2008;9(8):616-27.
27. Hu J, Sun L, Shen F, Chen Y, Hua Y, Liu Y, et al. The intra-S phase checkpoint targets Dna2 to prevent stalled replication forks from reversing. Cell. 2012;149(6):1221-32.
28. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408(6811):433-9.
29. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
30. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432(7015):316-23.
31. Pedroza-Garcia JA, Xiang Y, De Veylder L. Cell cycle checkpoint control in response to DNA damage by environmental stresses. Plant Sci. 2021;307:110902.
32. Hernández Borrero LJ, El-Deiry WS. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188556.
33. Barnum KJ, O’Connell MJ. Cell cycle regulation by checkpoints. Methods Mol Biol. 2014;1170:29-40.
34. Brito DA, Rieder CL. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Nat Cell Biol. 2006;8:1128-32.
35. Chan KS, Koh CG, Li HY. Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis. 2012;3:e411.
36. Dumontet C, Jordan MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov. 2010;9(10):790-803.
37. Tang A, Gao K, Chu L, Zhang R, Yang J, Zheng J. Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy. J Hematol Oncol. 2017;10(1):117.
38. Gjertsen BT, Schöffski P. Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy. Expert Opin Investig Drugs. 2015;24(1):85-96.
39. West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. Cancer Cell. 2014;26(1):81-91.